Famotidine can help gastritis by reducing the amount of acid your stomach produces, giving inflamed tissue a chance to heal. It works best for mild to moderate cases and is often a first-line option because it’s available over the counter, starts working within an hour, and carries fewer long-term risks than stronger acid-suppressing medications. That said, famotidine treats the symptom (excess acid irritating your stomach lining) rather than every possible underlying cause, so how much it helps depends on what’s driving your gastritis in the first place.
How Famotidine Reduces Stomach Acid
Your stomach lining contains parietal cells that pump out hydrochloric acid. One of the strongest signals telling those cells to ramp up production is histamine binding to H2 receptors on their surface. Famotidine blocks those receptors, which lowers both the volume and the acidity of your gastric secretions. It suppresses acid triggered by food, caffeine, and even the natural overnight surge your body produces while you sleep.
Because gastritis is fundamentally inflammation of the stomach lining, reducing acid exposure lets that lining recover. Less acid contact means less ongoing irritation, which translates to less burning, nausea, and upper-abdominal pain for most people.
How Quickly It Works and How Long It Lasts
Famotidine begins suppressing acid within about one hour of taking it orally. Peak effect hits somewhere between one and three hours, depending on the dose. A single 20 or 40 mg dose keeps acid levels lower for 10 to 12 hours, which is why it’s typically taken once or twice a day.
If you’re taking famotidine to prevent symptoms before a meal, the recommended window is 15 to 60 minutes beforehand. For ongoing gastritis treatment, consistency matters more than perfect meal timing. Most people notice meaningful symptom improvement within the first few days, though healing of the stomach lining itself takes longer.
What the Evidence Shows
Most clinical trials on famotidine have studied duodenal and gastric ulcers rather than gastritis specifically, but the conditions share the same basic problem: acid damaging vulnerable tissue. In a large multicenter trial of duodenal ulcers, famotidine at 40 mg once daily achieved a 70% healing rate at four weeks and 83% at eight weeks, compared to just 31% and 45% with placebo. Patients on famotidine also used fewer antacids and reported less pain throughout the study period.
Gastritis without ulceration is generally milder, so healing rates are expected to be at least comparable, and symptom relief often comes faster since there’s no deep crater in the tissue that needs to close. For many people with acute gastritis from dietary triggers, alcohol, or short-term NSAID use, famotidine provides enough acid suppression to resolve the flare within a few weeks.
How Famotidine Compares to PPIs
Proton pump inhibitors like omeprazole suppress acid more aggressively than famotidine. They block the final step of acid production rather than just one of the signals, so they reduce acid output by a larger margin. For erosive gastritis or severe symptoms, PPIs are generally the stronger choice.
The gap between the two isn’t always dramatic, though. In a randomized trial comparing famotidine 20 mg twice daily to omeprazole once daily for non-erosive symptoms, complete symptom relief at four weeks was 48% with famotidine versus 56% with omeprazole. In patients who tested positive for H. pylori, the two drugs performed almost identically (64% versus a similar rate with omeprazole). The advantage of omeprazole was clearest in H. pylori-negative patients, where famotidine’s complete relief rate dropped to 35%.
For mild gastritis, famotidine is a reasonable starting point. If your symptoms don’t improve after two to four weeks, switching to a PPI is the typical next step.
When H. pylori Is the Cause
H. pylori bacteria are one of the most common causes of chronic gastritis worldwide. Famotidine alone won’t eliminate the infection. You need antibiotics for that. However, famotidine can play a supporting role in eradication therapy.
A study testing a one-week course of high-dose famotidine combined with two antibiotics (amoxicillin and clarithromycin) found the regimen was highly effective at clearing the infection. The researchers concluded that acid suppression itself is the crucial factor that helps antibiotics work against H. pylori, and that famotidine provides enough suppression to fill that role. PPIs are still the more common choice in standard triple therapy protocols, but the finding confirms that famotidine’s acid reduction is meaningful even in infection-driven gastritis.
If your gastritis turns out to be caused by H. pylori, expect a combination treatment plan rather than famotidine on its own. The gastritis typically resolves once the bacteria are gone.
Standard Dosing
The FDA-approved doses for adults give a useful frame of reference. For active gastric ulcers, the labeled dose is 40 mg once daily. For milder acid-related conditions like non-erosive reflux symptoms, the dose is 20 mg twice daily. Over-the-counter famotidine (sold as Pepcid AC) comes in 10 mg and 20 mg tablets.
For gastritis that isn’t severe enough to warrant a prescription, many people start with 20 mg once or twice daily and adjust based on symptom response. Treatment courses typically run two to eight weeks. Maintenance dosing, when needed to prevent recurrence, is usually 20 mg once daily.
Long-Term Use and Tolerance
Famotidine has a favorable safety profile for short-term use. Common side effects are mild: headache, dizziness, and constipation or diarrhea. Serious reactions are rare.
Long-term use introduces two concerns worth knowing about. The first is tolerance. With prolonged daily use, your body can gradually adapt, and famotidine becomes less effective at suppressing acid over time. This is a well-documented characteristic of the entire H2 blocker class. If you find the medication losing its punch after several weeks, that’s likely what’s happening.
The second concern involves nutrient absorption. A large Kaiser Permanente study found that using H2 blockers or PPIs for two years or more significantly increased the risk of vitamin B12 deficiency. The risk was higher with PPIs, especially at high doses, but H2 blockers weren’t exempt. If you end up on famotidine for months rather than weeks, periodic B12 monitoring is reasonable.
These long-term issues are one reason famotidine works best as a bridge: it calms the inflammation while you address whatever triggered the gastritis, whether that’s an H. pylori infection, regular NSAID use, heavy alcohol intake, or chronic stress. Removing the trigger is what keeps gastritis from coming back once you stop the medication.
Where Famotidine Falls Short
Famotidine is less likely to be sufficient on its own for autoimmune gastritis, severe erosive gastritis, or gastritis caused by bile reflux. In autoimmune gastritis, the immune system attacks parietal cells directly, and acid suppression doesn’t address the underlying destruction. Bile reflux gastritis involves bile salts irritating the stomach lining rather than acid, so blocking acid production misses the point. Erosive gastritis with visible damage on endoscopy generally responds better to PPIs, which achieve a deeper and more sustained reduction in acid.
If you’ve been taking famotidine for more than two weeks without meaningful improvement in your symptoms, that’s a signal the gastritis may need a different approach, further evaluation, or a stronger acid suppressor.